|
Volumn 86, Issue 6, 2009, Pages 589-591
|
Clinical trial design in neonatal pharmacology: Effect of center differences, with lessons from the pediatric oncology cooperative research experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE LYMPHOCYTIC LEUKEMIA;
ADVERSE OUTCOME;
CANCER INCIDENCE;
CANCER RESEARCH;
CANCER SURVIVAL;
CHILDHOOD CANCER;
CHRONIC LUNG DISEASE;
CLINICAL TRIAL;
CONVALESCENCE;
DRUG EFFICACY;
DRUG SAFETY;
GENOMICS;
HEALTH CARE FACILITY;
HUMAN;
INFECTION PREVENTION;
MORBIDITY;
NEONATOLOGY;
NEPHROBLASTOMA;
NEUROLOGIC DISEASE;
NEWBORN;
NEWBORN INTENSIVE CARE;
OPEN STUDY;
OUTCOME ASSESSMENT;
PEDIATRIC SURGERY;
PREMATURITY;
PRIORITY JOURNAL;
RETROLENTAL FIBROPLASIA;
RISK FACTOR;
SHORT SURVEY;
SURVIVAL TIME;
TREATMENT DURATION;
VERY LOW BIRTH WEIGHT;
CHILD, PRESCHOOL;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
EVIDENCE-BASED MEDICINE;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFANT, NEWBORN, DISEASES;
INFANT, PREMATURE;
INFANT, PREMATURE, DISEASES;
INTENSIVE CARE UNITS, NEONATAL;
MULTICENTER STUDIES AS TOPIC;
PRACTICE GUIDELINES AS TOPIC;
QUALITY OF HEALTH CARE;
RESEARCH DESIGN;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 70450142688
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2009.175 Document Type: Short Survey |
Times cited : (5)
|
References (5)
|